JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
JNCE
Delisted
JNCE was delisted on the 3rd of May, 2023.
94 hedge funds and large institutions have $669M invested in Jounce Therapeutics, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 26 increasing their positions, 29 reducing their positions, and 14 closing their positions.
Holders
94
Holders Change
+11
Holders Change %
+13.25%
% of All Funds
2.16%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
26
Increased
26
Reduced
29
Closed
14
Calls
$21.4M
Puts
$1.58M
Net Calls
+$19.8M
Net Calls Change
+$20M
